Cargando…
Pharmacological Approaches to Controlling Cardiometabolic Risk in Women with PCOS
Polycystic ovary syndrome (PCOS) is characterized by elevated androgen production and subclinical changes in cardiovascular and metabolic risk markers. Total cholesterol, high-density lipoprotein (HDL) cholesterol, fasting glucose, and fasting insulin appear to increase specifically in PCOS compared...
Autores principales: | Cignarella, Andrea, Mioni, Roberto, Sabbadin, Chiara, Dassie, Francesca, Parolin, Matteo, Vettor, Roberto, Barbot, Mattia, Scaroni, Carla |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7765466/ https://www.ncbi.nlm.nih.gov/pubmed/33334002 http://dx.doi.org/10.3390/ijms21249554 |
Ejemplares similares
-
Practical Considerations for the Management of Cushing's Disease and COVID-19: A Case Report
por: Beretta, Federica, et al.
Publicado: (2020) -
Do Androgenic Pattern, Insulin State and Growth Hormone Affect Cardiorespiratory Fitness and Strength in Young Women with PCOS?
por: Baioccato, Veronica, et al.
Publicado: (2022) -
The Endothelium in Acromegaly
por: Maffei, Pietro, et al.
Publicado: (2019) -
Imaging or Adrenal Vein Sampling Approach in Primary Aldosteronism? A Patient-Based Approach
por: Tizianel, Irene, et al.
Publicado: (2022) -
Improved salivary cortisol rhythm with dual-release hydrocortisone
por: Ceccato, Filippo, et al.
Publicado: (2018)